Selecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention

Shailja V Parikh1, Ellen C Keeley21Departments of Internal Medicine, Divisions of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas, 2University of Virginia, Charlottesville, Virginia, USAAbstract: The wide variety of anticoagulant and antiplatelet agents available for clini...

Full description

Bibliographic Details
Main Authors: Shailja V Parikh, Ellen C Keeley
Format: Article
Language:English
Published: Dove Medical Press 2009-08-01
Series:Vascular Health and Risk Management
Online Access:http://www.dovepress.com/selecting-the-optimal-antithrombotic-regimen-for-patients-with-acute-c-a3459
id doaj-fb56110487154686b36e28a2d1beeefb
record_format Article
spelling doaj-fb56110487154686b36e28a2d1beeefb2020-11-24T21:14:36ZengDove Medical PressVascular Health and Risk Management1176-63441178-20482009-08-012009default677691Selecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary interventionShailja V ParikhEllen C KeeleyShailja V Parikh1, Ellen C Keeley21Departments of Internal Medicine, Divisions of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas, 2University of Virginia, Charlottesville, Virginia, USAAbstract: The wide variety of anticoagulant and antiplatelet agents available for clinical use has made choosing the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention a complex task. While there is no single best regimen, from a risk-benefit ratio standpoint, particular regimens may be considered optimal for different patients. We review the mechanisms of action for the commonly prescribed antithrombotic medications, summarize pertinent data from randomized trials on their use in acute coronary syndromes, and provide an algorithm (incorporating data from these trials as well as risk assessment instruments) that will help guide the decision-making process.Keywords: anticoagulant, antiplatelet, percutaneous coronary intervention http://www.dovepress.com/selecting-the-optimal-antithrombotic-regimen-for-patients-with-acute-c-a3459
collection DOAJ
language English
format Article
sources DOAJ
author Shailja V Parikh
Ellen C Keeley
spellingShingle Shailja V Parikh
Ellen C Keeley
Selecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention
Vascular Health and Risk Management
author_facet Shailja V Parikh
Ellen C Keeley
author_sort Shailja V Parikh
title Selecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention
title_short Selecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention
title_full Selecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention
title_fullStr Selecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention
title_full_unstemmed Selecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention
title_sort selecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention
publisher Dove Medical Press
series Vascular Health and Risk Management
issn 1176-6344
1178-2048
publishDate 2009-08-01
description Shailja V Parikh1, Ellen C Keeley21Departments of Internal Medicine, Divisions of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas, 2University of Virginia, Charlottesville, Virginia, USAAbstract: The wide variety of anticoagulant and antiplatelet agents available for clinical use has made choosing the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention a complex task. While there is no single best regimen, from a risk-benefit ratio standpoint, particular regimens may be considered optimal for different patients. We review the mechanisms of action for the commonly prescribed antithrombotic medications, summarize pertinent data from randomized trials on their use in acute coronary syndromes, and provide an algorithm (incorporating data from these trials as well as risk assessment instruments) that will help guide the decision-making process.Keywords: anticoagulant, antiplatelet, percutaneous coronary intervention
url http://www.dovepress.com/selecting-the-optimal-antithrombotic-regimen-for-patients-with-acute-c-a3459
work_keys_str_mv AT shailjavparikh selectingtheoptimalantithromboticregimenforpatientswithacutecoronarysyndromesundergoingpercutaneouscoronaryintervention
AT ellenckeeley selectingtheoptimalantithromboticregimenforpatientswithacutecoronarysyndromesundergoingpercutaneouscoronaryintervention
_version_ 1716746575619817472